|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 221.38 USD | +0.03% |
|
-.--% | +0.22% |
| 01-08 | Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2000 Value Benchmark | CI |
| 01-08 | Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2500 Value Benchmark | CI |
Company Valuation: Cidara Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 126.9 | 87.88 | 84.69 | 54.16 | 71.8 | 294 |
| Change | - | -30.74% | -3.62% | -36.04% | 32.57% | 309.5% |
| Enterprise Value (EV) 1 | 88.33 | 59.93 | 30.07 | 22.75 | 40.9 | 107.8 |
| Change | - | -32.16% | -49.82% | -24.35% | 79.79% | 163.52% |
| P/E | -2.72x | -1.11x | -1.57x | -1.76x | -3.03x | -1.01x |
| PBR | 3.43x | 8.38x | 4x | -18.9x | -8.76x | 1.8x |
| PEG | - | -0x | 0x | 0x | 0.1x | -0x |
| Capitalization / Revenue | 6.07x | 7.28x | 1.71x | 0.84x | 1.12x | 231x |
| EV / Revenue | 4.22x | 4.97x | 0.61x | 0.35x | 0.64x | 84.5x |
| EV / EBITDA | -2.13x | -0.84x | -0.71x | -0.77x | -1.68x | -1.18x |
| EV / EBIT | -2.12x | -0.83x | -0.71x | -0.77x | -1.67x | -1.18x |
| EV / FCF | -3.65x | -1.69x | -2.24x | -1.45x | 61.6x | -1.61x |
| FCF Yield | -27.4% | -59.1% | -44.7% | -69.1% | 1.62% | -62.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -28.25 | -36.03 | -16.19 | -8.6 | -5.246 | -26.75 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 20.92 | 12.07 | 49.57 | 64.29 | 63.9 | 1.275 |
| EBITDA 1 | -41.4 | -71.56 | -42.07 | -29.58 | -24.37 | -91.06 |
| EBIT 1 | -41.72 | -71.85 | -42.26 | -29.72 | -24.48 | -91.22 |
| Net income 1 | -41.09 | -72.11 | -42.47 | -29.8 | -22.93 | -169.8 |
| Net Debt 1 | -38.54 | -27.95 | -54.62 | -31.41 | -30.9 | -186.2 |
| Reference price 2 | 76.80 | 40.00 | 25.40 | 15.13 | 15.88 | 26.88 |
| Nbr of stocks (in thousands) | 1,652 | 2,197 | 3,334 | 3,581 | 4,522 | 10,939 |
| Announcement Date | 3/4/20 | 2/25/21 | 3/7/22 | 3/23/23 | 4/22/24 | 3/6/25 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CDTX Stock
- Valuation Cidara Therapeutics
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
